Tumor Burden Talks in Cancer Treatment with PEGylated Liposomal Drugs

Abstract

The significant differences in the outcomes of cancer treatment and molecular imaging between animals bearing small and large tumors revealed that tumor burden is a critical and discriminative factor in cancer therapy using PEGylated liposomal drugs.